CFLAR and cancer: This chemoresistance may be due to downregulation of cell surface death receptors and/or up-regulation of anti-apoptotic proteins such as Bcl-2 like, cFLIP, or IAPs, making the targeting of those molecules an attractive and important task in the development of the next generation cancer chemotherapies (Figure 1).